Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene

View through CrossRef
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX. Bleeding into joints is the most frequent manifestation of hemophilia. Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS). In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops. Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known. Iron has long been suspected to be the culprit but direct evidence has been lacking. Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression. Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2. Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold. In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation. Iron, in vitro, induced the expression of mdm2. The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis. (Blood. 2004;104:2060-2064)
Title: Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene
Description:
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX.
Bleeding into joints is the most frequent manifestation of hemophilia.
Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS).
In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops.
Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known.
Iron has long been suspected to be the culprit but direct evidence has been lacking.
Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression.
Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2.
Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold.
In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation.
Iron, in vitro, induced the expression of mdm2.
The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis.
(Blood.
2004;104:2060-2064).

Related Results

Abstract 1234: Impact of cancer-associated mutations on MDM2 function
Abstract 1234: Impact of cancer-associated mutations on MDM2 function
Abstract MDM2 is an E3 ubiquitin ligase that functions as a negative regulator of the tumor suppressor p53. MDM2 can promote the ubiquitination and proteasomal degra...
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
Repeated intra-articular hemorrhages lead to hemophilic arthropathy in severe hemophilia. Inflammation and pro-inflammatory cytokines (e.g., tumor necrosis factor alpha (TNFα)) mig...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Synthesis and Evaluation of RG7388-Based Fluorinated MDM2 Inhibitors for Developing 18F-Labeled Probes for PET Imaging
Synthesis and Evaluation of RG7388-Based Fluorinated MDM2 Inhibitors for Developing 18F-Labeled Probes for PET Imaging
MDM2 (murine double minute 2) is a negative regulator of the tumor suppressor protein p53 and is frequently overexpressed in sarcomas. MDM2 inhibition with small-molecule and pepti...
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
Inhibition of the MDM2/X-p53 interaction is recognized as a potential anti-cancer strategy, including the treatment of glioblastoma (GB). In response to cellular stressors, such as...

Back to Top